Literature DB >> 6194614

Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus.

L Kingsford, L D Ishizawa, D W Hill.   

Abstract

Monoclonal antibodies have been prepared which are specific for the G1 glycoprotein of La Crosse virus. By competitive radioimmunoassay, 20 IgG-producing clones were found to map in eight antigenic sites; three distinct and five which showed individual patterns of partial competition indicating they may be in close proximity. Unique in situ trypsin cleavage sites on G1 have helped in orienting these defined epitopes relative to the viral membrane. Antibody molecules belonging to one epitope (H) mapped on the trypsin-resistant part of G1 and had negative or extremely low neutralizing and hemagglutination inhibition activities. Seven epitopes were located on the trypsin-sensitive part of G1, a 25,000-Da region which is probably the amino terminus of the protein. Antibodies binding to six of these seven epitopes (A, B, D, E, F, and G) were positive for neutralization and inhibition of hemagglutination, but exhibited a wide range of activities. Epitopes A, F, and G seem to be in an immunodominant region containing the primary site(s) for attachment to cell receptors. Antibody specific for the remaining epitope (C) was unique in that it bound to a site closely adjacent to neutralizing antibody sites, enhanced antibody binding to epitopes A and G, but lacked the capacity to neutralize viral infectivity or inhibit hemagglutination. Enhancement of antibody binding also occurred between two other closely adjacent sites (B and D) and one other distinct epitope (G). In addition, antibody from an IgM-producing clone competed with antibodies to these same four epitopes (B, C, D, and G), indicating they are in close proximity. These data have been used to construct an antigenic map that may now be used as a working model for the study of virus neutralization.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194614     DOI: 10.1016/0042-6822(83)90182-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  A Genome-Wide CRISPR-Cas9 Screen Reveals the Requirement of Host Cell Sulfation for Schmallenberg Virus Infection.

Authors:  Thiprampai Thamamongood; Andrea Aebischer; Valentina Wagner; Max W Chang; Roland Elling; Christopher Benner; Adolfo García-Sastre; Georg Kochs; Martin Beer; Martin Schwemmle
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies.

Authors:  T G Besselaar; N K Blackburn
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 3.  Monoclonal antibodies: implications for virology. Brief review.

Authors:  K C McCullough
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.

Authors:  A Pekosz; C Griot; K Stillmock; N Nathanson; F Gonzalez-Scarano
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

5.  Neutralizing determinants defined by monoclonal antibodies on polypeptides specified by bovine herpesvirus 1.

Authors:  J K Collins; A C Butcher; C A Riegel; V McGrane; C D Blair; Y A Teramoto; S Winston
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

6.  An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function.

Authors:  F Gonzalez-Scarano; R S Janssen; J A Najjar; N Pobjecky; N Nathanson
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

7.  Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.

Authors:  Andrea Bertolotti-Ciarlet; Jonathan Smith; Karin Strecker; Jason Paragas; Louis A Altamura; Jeanne M McFalls; Natalia Frias-Stäheli; Adolfo García-Sastre; Connie S Schmaljohn; Robert W Doms
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Epitopes functional in neutralization of varicella-zoster virus.

Authors:  B Forghani; K W Dupuis; N J Schmidt
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

9.  Prevalence and protein specificity of human antibodies to Inkoo virus infection.

Authors:  Niina Putkuri; Antti Vaheri; Olli Vapalahti
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

10.  Functional analysis of the Bunyamwera orthobunyavirus Gc glycoprotein.

Authors:  Xiaohong Shi; Josthna Goli; Gordon Clark; Kristina Brauburger; Richard M Elliott
Journal:  J Gen Virol       Date:  2009-07-01       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.